TY  - JOUR 
AU  - Gaibar Alonso, María
AU  - Novillo, Apolonia
AU  - Romero, Alicia
AU  - Fernandez, Ana
AU  - Malón, Diego
AU  - Antón, Beatriz
AU  - Moreno, Amalia
PY  - 2023
UR  - http://hdl.handle.net/20.500.12020/985
AB  - The addition to chemotherapy of anti-HER2 drugs such as trastuzumab or pertuzumab has
improved outcomes in HER2-positive breast cancer patients. However, resistance to these drugs in
some patients remains a major concern. This study examines the...
LA  - en
PB  - MDPI
TI  - HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment
DO  - https://doi.org/10.3390/cancers15030763
T2  - Cancers
M2  - 763
KW  - HER2-positive breast cancer
KW  - Anti-HER2 treatment
KW  - HER2 gene
KW  - SNPs
KW  - Pathological complete response
KW  - Miller–Payne grading
VL  - 15
ER  -